Dudley & Shanley, Inc. Ocular Therapeutix, Inc Transaction History
Dudley & Shanley, Inc.
- $612 Million
- Q2 2025
A detailed history of Dudley & Shanley, Inc. transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Dudley & Shanley, Inc. holds 16,400 shares of OCUL stock, worth $204,672. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,400
Previous 16,200
1.23%
Holding current value
$204,672
Previous $122,000
24.59%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding OCUL
# of Institutions
209Shares Held
135MCall Options Held
426KPut Options Held
119K-
Deep Track Capital, LP Greenwich, CT14.3MShares$178 Million3.66% of portfolio
-
Summer Road LLC West Palm Beach, FL13.9MShares$173 Million98.53% of portfolio
-
Vr Adviser, LLC New York, NY12.8MShares$159 Million22.59% of portfolio
-
Black Rock Inc. New York, NY11.5MShares$144 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.39MShares$105 Million0.0% of portfolio
About OCULAR THERAPEUTIX, INC
- Ticker OCUL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,966,896
- Market Cap $961M
- Description
- Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...